Syndax Pharmaceuticals SNDX Business Segments — Other General And Administrative Expense

Similar metrics at other companies

DNLITherapeutics Segment — Other general and administrative expenses

$10.95M+3.1%

ANABBiopharma Company — General And Administrative Expense

$18.86M+92.1%

VCYTBiopharmaceutical and other revenue — Other cost

$8K-99.2%

LHBiopharma Laboratory Services — Other Cost and Expense, Operating

$89.7M-0.3%

DNLITherapeutics Segment — Personnel related general and administrative expenses

$22.56M+20.4%

VRTXPharmaceuticals — General and administrative expenses

$180.1M+16.0%

Questions, answered.

What is Syndax Pharmaceuticals's business segments — other general and administrative expense?

Syndax Pharmaceuticals (SNDX) reported business segments — other general and administrative expense of $5.14M in Q1 2026.

How has Syndax Pharmaceuticals's business segments — other general and administrative expense changed year-over-year?

Syndax Pharmaceuticals's business segments — other general and administrative expense increased by 16.5% year-over-year, from $4.41M to $5.14M.

What is the long-term trend for Syndax Pharmaceuticals's business segments — other general and administrative expense?

Over 3 years (2022 to 2025), Syndax Pharmaceuticals's business segments — other general and administrative expense has grown at a 33.3% compound annual growth rate (CAGR), from $9.84M to $23.31M.

What does business segments — other general and administrative expense mean?

This includes miscellaneous administrative costs such as legal, consulting, and facility expenses allocated to the cancer therapeutics segment. It represents the non-personnel overhead required to maintain the business unit's infrastructure. Consistent monitoring helps identify trends in corporate overhead and operational efficiency.